UB Paderborn / Katalog / Suche / in CDI

Es ist ein Fehler in der Kommunikation mit einem externen System aufgetreten. Bitte versuchen Sie Ihre letzte Aktion erneut. Sollte der Fehler bestehen bleiben, setzen Sie sich bitte mit dem Informationszentrum der Bibliothek in Verbindung oder versuchen Sie es später erneut.

1 – 25 von 149

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacogenetics: From Bench to Byte- An Update of Guidelines

Clinical pharmacology and therapeutics, 2011-05, Vol.89 (5), p.662-673

2011

Volltextzugriff (PDF)

A simple dried blood spot method for therapeutic drug monitoring of the tricyclic antidepressants amitriptyline, nortriptyline, imipramine, clomipramine, and their active metabolites using LC-MS/MS

Talanta (Oxford), 2015-03, Vol.134, p.165-172

2015

Volltextzugriff (PDF)

Relation between CYP2D6 Genotype, Phenotype and Therapeutic Drug Concentrations among Nortriptyline and Venlafaxine Users in Old Age Psychiatry

Pharmacopsychiatry, 2016-09, Vol.49 (5), p.186-190

2016

Volltextzugriff (PDF)

Pharmacogenetics: From Bench to Byte

Clinical pharmacology and therapeutics, 2008-05, Vol.83 (5), p.781-787

2008

Volltextzugriff (PDF)

Determination of venlafaxine and O-desmethylvenlafaxine in dried blood spots for TDM purposes, using LC-MS/MS

Analytical and bioanalytical chemistry, 2014-04, Vol.406 (9-10), p.2349-2353

2014

Volltextzugriff (PDF)

Gene polymorphism of serotonin receptors and drug-induced hyperprolactinemia in schizophrenic patients

European neuropsychopharmacology, 2016-10, Vol.26, p.S515-S516

2016

Volltextzugriff (PDF)

CYP2D6 and catechol-O-methyltransferase gene polymorphisms in Parkinson patients with levodopa-induced dyskinesias

European neuropsychopharmacology, 2016-10, Vol.26, p.S656-S657

2016

Volltextzugriff (PDF)

P.5.d.005 Polymorphisms of DRD2, DRD3, DRD4 and HTR2C genes in levodopa-induced dyskinesias in Parkinson's disease

European neuropsychopharmacology, 2015-09, Vol.25, p.S589-S589

2015

Volltextzugriff (PDF)

Pharmacokinetics of clomipramine during pregnancy

European journal of clinical pharmacology, 2015-12, Vol.71 (12), p.1493-1500

2015

Volltextzugriff (PDF)

4-Aminopyridine as a life-saving treatment in calcium channel antagonist intoxication

Netherlands journal of medicine, 2016-07, Vol.74 (6), p.276-276

2016

Volltextzugriff (PDF)

Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia

Progress in neuro-psychopharmacology & biological psychiatry, 2009-04, Vol.33 (3), p.475-481

2009

Volltextzugriff (PDF)

P.3.a.006 Tardive dyskinesia, dehydroepiandrosterone sulfate and cytochrome P450c17α gene polymorphism in psychiatric inpatients

European neuropsychopharmacology, 2014-10, Vol.24, p.S486-S487

2014

Volltextzugriff (PDF)

Influencing CYP enzymes to boost psychiatric treatment: a review on clinical evidence

Pharmacopsychiatry, 2013-03, Vol.46 (2), p.43-46

2013

Volltextzugriff (PDF)

In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children

European journal of clinical pharmacology, 2013-03, Vol.69 (3), p.541-547

2013

Volltextzugriff (PDF)

P.583 Polymorphisms in BDNF, AKT1, GSK3B genes: possible association with antipsychotic-induced hyperprolactinemia in schizophrenia patients

European neuropsychopharmacology, 2020-11, Vol.40, p.S331-S332

2020

Volltextzugriff (PDF)

P.0579 Pharmacogenetic study to elucidate putative dopaminergic mechanisms of antidepressant action

European neuropsychopharmacology, 2021-12, Vol.53, p.S424-S425

2021

Volltextzugriff (PDF)

CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers : indications for oral contraceptive-related gender differences

European journal of clinical pharmacology, 1999-05, Vol.55 (3), p.177-184

1999

Volltextzugriff (PDF)

Aconitum sp. alkaloids: the modulation of voltage-dependent Na + channels, toxicity and antinociceptive properties

European journal of pharmacology, 1997-10, Vol.337 (2), p.165-174

1997

Volltextzugriff (PDF)

P.3.001 NMDA receptor co-determines vulnerability to develop dyskinesia in Huntington's Disease and levodopa-induced dyskinesia but not tardive dyskinesia

European neuropsychopharmacology, 2011, Vol.21, p.S142-S142

2011

Volltextzugriff (PDF)

P.3.c.002 Association between the alpha-2a-adrenergic receptor 1291 C/G polymorphism and the metabolic syndrome

European neuropsychopharmacology, 2010, Vol.20, p.S458-S459

2010

Volltextzugriff (PDF)

P.3.c.001 Association between HTR2C polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study

European neuropsychopharmacology, 2010, Vol.20, p.S458-S458

2010

Volltextzugriff (PDF)

Tardive dyskinesia in schizophrenia: Gene polymorphisms of muscarinic and adrenergic receptors

European neuropsychopharmacology, 2019, Vol.29, p.S117-S118

2019

Volltextzugriff (PDF)

The study of dopamine receptor genes in patients with schizophrenia

European neuropsychopharmacology, 2019, Vol.29, p.S410-S411

2019

Volltextzugriff (PDF)

Concordance assessment of self-reported medication use in the Netherlands three-generation Lifelines Cohort study with the pharmacy database iaDB.nl: The PharmLines initiative

Clinical epidemiology, 2018-01, Vol.10, p.981-989

2018

Volltextzugriff (PDF)

LACK OF ASSOCIATION BETWEEN rs4606 SNP OF THE RGS2 GENE AND ANTIPSYCHOTIC-INDUCED PARKINSONISM, TREMOR, BRADYKINESIA, AND RIGIDITY IN AFRO-CARIBBEAN INPATIENTS

Schizophrenia research, 2008, Vol.102 (1), p.235-236

2008

Volltextzugriff (PDF)

1 – 25 von 149

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(133)

Publikationsform

Artikel
(149)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacogenetics: From Bench to Byte- An Update of Guidelines

A simple dried blood spot method for therapeutic drug monitoring of the tricyclic antidepressants amitriptyline, nortriptyline, imipramine, clomipramine, and their active metabolites using LC-MS/MS

Relation between CYP2D6 Genotype, Phenotype and Therapeutic Drug Concentrations among Nortriptyline and Venlafaxine Users in Old Age Psychiatry

Pharmacogenetics: From Bench to Byte

Determination of venlafaxine and O-desmethylvenlafaxine in dried blood spots for TDM purposes, using LC-MS/MS

Gene polymorphism of serotonin receptors and drug-induced hyperprolactinemia in schizophrenic patients

CYP2D6 and catechol-O-methyltransferase gene polymorphisms in Parkinson patients with levodopa-induced dyskinesias

P.5.d.005 Polymorphisms of DRD2, DRD3, DRD4 and HTR2C genes in levodopa-induced dyskinesias in Parkinson's disease

Pharmacokinetics of clomipramine during pregnancy

4-Aminopyridine as a life-saving treatment in calcium channel antagonist intoxication

Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia

P.3.a.006 Tardive dyskinesia, dehydroepiandrosterone sulfate and cytochrome P450c17α gene polymorphism in psychiatric inpatients

Influencing CYP enzymes to boost psychiatric treatment: a review on clinical evidence

In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children

P.583 Polymorphisms in BDNF, AKT1, GSK3B genes: possible association with antipsychotic-induced hyperprolactinemia in schizophrenia patients

P.0579 Pharmacogenetic study to elucidate putative dopaminergic mechanisms of antidepressant action

CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers : indications for oral contraceptive-related gender differences

Aconitum sp. alkaloids: the modulation of voltage-dependent Na + channels, toxicity and antinociceptive properties

P.3.001 NMDA receptor co-determines vulnerability to develop dyskinesia in Huntington's Disease and levodopa-induced dyskinesia but not tardive dyskinesia

P.3.c.002 Association between the alpha-2a-adrenergic receptor 1291 C/G polymorphism and the metabolic syndrome

P.3.c.001 Association between HTR2C polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study

Tardive dyskinesia in schizophrenia: Gene polymorphisms of muscarinic and adrenergic receptors

The study of dopamine receptor genes in patients with schizophrenia

Concordance assessment of self-reported medication use in the Netherlands three-generation Lifelines Cohort study with the pharmacy database iaDB.nl: The PharmLines initiative

LACK OF ASSOCIATION BETWEEN rs4606 SNP OF THE RGS2 GENE AND ANTIPSYCHOTIC-INDUCED PARKINSONISM, TREMOR, BRADYKINESIA, AND RIGIDITY IN AFRO-CARIBBEAN INPATIENTS

Aktive Filter

Suchergebnisse filtern